Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist

Compiled from ClinicalTrials.gov and CTIS registry records · Last verified 26 Sep 2026 · Editorial standards

At a glance

Affiliated Hospital of Nantong University is the lead sponsor of 36 current clinical trials in our China register. 26 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Dexmedetomidine, 3TC and B/F/TAF. The most-studied condition is Ischemic Stroke.

ClinicalTrials.gov trials by status

Recruiting2672%
Not yet open411%
Active, closed38%
By invitation38%

Trials by phase

Not applicable1542%
Observational925%
Phase 4411%
Phase 2411%
Phase 1/226%
Phase 313%
Phase EARLY_PHASE113%

Clinical trials sponsored by Affiliated Hospital of Nantong University

36 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
Prospective Cohort Control Study on Changes in Gut Microbiota in Ischemic Stroke NCT07247838 · ClinicalTrials.gov ↗ · Ischemic Stroke	Observational	Recruiting	2025-11	China
Clinical Study of SMILE 4.0-VISULYZE in Correcting Refractive Errors NCT06982807 · ClinicalTrials.gov ↗ · Refractive Surgery, Myopia; Refractive Error	Not applicable	Recruiting	2024-11	China
Effect of Dexmedetomidine Combined With FNB/ACB on Sleep Quality After Knee Surgery NCT07767383 · ClinicalTrials.gov ↗ · Knee Arthroscopic Surgery Drugs: Dexmedetomidine, Ropivacaine	Phase 4	Recruiting	2026-01	China
Dexmedetomidine Combined With Transcutaneous Vagus Nerve Stimulation (taVNS) Can Reduce the Incidence of PTSD in Trauma Patients After Surgery NCT07813962 · ClinicalTrials.gov ↗ · PTSD - Post Traumatic Stress Disorder, taVNS, Dexmedetomidine Drug: Dexmedetomidine	Not applicable	Recruiting	2026-09	China
Rapid and Safe Sputum Suction Method Validation NCT06508008 · ClinicalTrials.gov ↗ · Sputum	Not applicable	Recruiting	2024-02	China
Microfracture at Proximal Humerus Lateral to Footprint Could Enhance the Rotator Cuff Healing NCT05624164 · ClinicalTrials.gov ↗ · Rotator Cuff Tears, Micro Fracture	Not applicable	Recruiting	2022-10	China
Clinical Application Research of 5-Degree (0.05 D) Precision Optometry in Corneal Refractive Surgery NCT07146828 · ClinicalTrials.gov ↗ · Refractive Surgery	Not applicable	Recruiting	2025-01	China
Laparoscopic Surgical Systems for Gynecological and Remote Surgical Treatment. NCT06676267 · ClinicalTrials.gov ↗ · Gynecological Cancer	Not applicable	Recruiting	2024-08	China
Pretreatment With HCQ Before Radiotherapy and Chemotherapy in Advanced NPC Patients NCT06389201 · ClinicalTrials.gov ↗ · Nasopharyngeal Carcinoma	Not applicable	Recruiting	2024-08	China
A Study of CAR T-Cells in Relapsed/Refractory Hematologic Malignancy NCT06756321 · ClinicalTrials.gov ↗ · Relapsed/refractory Lymphoma, Relapsed/Refractory Leukemia Drugs: Cyclophosphamide, Fludarabine	Phase EARLY_PHASE1	Recruiting	2023-09	China
A Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic Seizures NCT06967012 · ClinicalTrials.gov ↗ · Epilepsies, Partial, Epilepsy, Tonic-Clonic	Phase 4	Recruiting	2024-08	China
Latent Infection Freshmen Tracking for Tuberculosis NCT07811518 · ClinicalTrials.gov ↗ · Latent Tuberculosis Infection (LTBI), Tuberculosis (TB)	Phase 4	Recruiting	2022-08	China
The Safety and Efficacy of Radiofrequency Ablation After Left Atrial Appendage Occlusion. NCT06984731 · ClinicalTrials.gov ↗ · Cardiovascular Diseases, Arrhythmia	Observational	Recruiting	2025-04	China
Mitoxantrone Hydrochloride Liposome Combination Regimen in the Treatment of High-risk/Extramedullary Multiple Myeloma NCT06246162 · ClinicalTrials.gov ↗ · Multiple Myeloma	Phase 1/2	Recruiting	2023-11	China
Oxycodone Versus Sufentanil in Patient-controlled Intravenous Analgesia After Laparoscopic Hysterectomy NCT06690307 · ClinicalTrials.gov ↗ · Laparoscopic Hysterectomy	Phase 4	Recruiting	2024-12	China
Venetoclax Combined with Intensive Therapy for Acute Myeloid Leukemia Patients with Lower Early Peripheral Blast Clearance Rate After Standard Induction Therapy NCT06643962 · ClinicalTrials.gov ↗ · Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Drugs: Cytarabine, Venetoclax	Not applicable	Recruiting	2024-10	China
Clinical Study of Thiopegfilgrastim for Preventing Bone Marrow Suppression in Thoracic Tumor Chemoradiotherapy NCT07205536 · ClinicalTrials.gov ↗ · Myelosuppression, Thoracic Neoplasms, Chemoradiotherapy Drug: Mecapegfilgrastim	Phase 2	Recruiting	2025-08	China
Study on the Molecular Mechanism of Berberine to Improve Type 2 Diabetes Mellitus Complicated With Depression NCT06979440 · ClinicalTrials.gov ↗ · Diabetes-Related Complications	Observational	Recruiting	2024-11	China
Effects of taVNS Combined With Dexmedetomidine on POVN NCT07271147 · ClinicalTrials.gov ↗ · Postoperative Nausea and Vomiting Drug: Dexmedetomidine	Not applicable	Recruiting	2025-11	China
tDCS for Reducing the Incidence of OEI After Cesarean Section NCT07569783 · ClinicalTrials.gov ↗ · Itching Symptoms, Itching Caused by Epidural Use of Opioids	Not applicable	Recruiting	2026-05	China
Evaluation of Irinotecan Liposome (II) Combined With 5-FU, LV, and Bevacizumab for mCRC NCT06643793 · ClinicalTrials.gov ↗ · Colorectal Neoplasms Malignant	Phase 2	Recruiting	2024-11	China
Wearable Devices Empowering Active Health Initiatives for High-Risk Stroke Populations NCT06935513 · ClinicalTrials.gov ↗ · Hypertension, Diabetes, Atrial Fibrillation	Not applicable	Recruiting	2025-04	China
QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Triple-Negative Breast Cancer NCT07342283 · ClinicalTrials.gov ↗ · Triple Negative Breast Cancer (TNBC)	Phase 2	Recruiting	2026-02	China
Study of Sivelestat Sodium in OPCABG NCT07118930 · ClinicalTrials.gov ↗ · Coronary Heart Disease, Coronary Artery Disease, Coronary Arterial Disease (CAD)	Phase 2	Recruiting	2025-08	China
Dynamic Airway Resistance & ML: Guide Sputum Suction in Ventilated Patients NCT07375667 · ClinicalTrials.gov ↗ · Mechanical Ventilation Pressure High, Ventilator-Associated Pneumonia (VAP), Respiratory Depression Neonatal	Not applicable	Recruiting	2025-10	China
Good-first: B/F/TAF As First-line ART NCT06619288 · ClinicalTrials.gov ↗ · HIV Infection Drugs: 3TC, B/F/TAF, Dolutegravir / Lamivudine	Observational	Recruiting	2024-07	China
Clinical Study on the Efficacy and Safety of Hydromorphone for ICU Analgesia NCT06848452 · ClinicalTrials.gov ↗ · Analgesia, ICU Patients Requiring Invasive Mechanical Ventilation	Observational	Not yet open	2025-03	China
Prevention of Ischemic Stroke Recurrence Using Digital Technology Application NCT07825311 · ClinicalTrials.gov ↗ · Ischemic Stroke, Digital Health	Not applicable	Not yet open	2026-09	China
The Impact of Smoking on the Prognosis of Elderly Surgical Patients NCT06392308 · ClinicalTrials.gov ↗ · Delirium, Postoperative	Observational	Not yet open	2025-09	China
Autologous Bone Marrow Mesenchymal Stem Cell Therapy for Ischemic Stroke NCT06997939 · ClinicalTrials.gov ↗ · Ischemic Stroke	Phase 1/2	Not yet open	2025-06	China
Intravitreal and Intracameral DEX in NPDR NCT06951087 · Non-Proliferative Diabetic Retinopathy	Phase 3	By invitation	2022-01	China
The Safety and Efficacy of Pulsed Field Ablation for Patients With Persistent Atrial Fibrillation Comorbid With HFpEF. NCT07077811 · ClinicalTrials.gov ↗ · Cardiovascular Diseases, Heart Failure, Atrial Fibrillation (AF)	Not applicable	By invitation	2025-06	China
Screening of Small Non-coding RNAs as an Auxiliary Diagnostic Biomarker for Gastric Cancer NCT06776835 · ClinicalTrials.gov ↗ · Stomach Neoplasms	Observational	By invitation	2023-12	China
Research and Application Evaluation of Accurate Pressure Ulcer Area Measurement Technology Based on AI Grid Intelligent Recognition: A Self-controlled Study NCT07743385 · ClinicalTrials.gov ↗ · Pressure Ulcers, Pressure Injuries	Not applicable	Active, closed	2026-07	China
Effectiveness and Cost-effectiveness of VTE Prevention Strategies in Gynecological Surgery NCT07455253 · ClinicalTrials.gov ↗ · Venous Thromboembolism, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE)	Observational	Active, closed	2025-11	China
TS Triage of HR-HPV Positive Population and Its Accuracy Study NCT07777094 · ClinicalTrials.gov ↗ · Cervical Precancerous Lesions, Cervical Cancer	Observational	Active, closed	2024-10	China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Drugs in Affiliated Hospital of Nantong University trials

10 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

Dexmedetomidine3 3TC1 B/F/TAF1 Cyclophosphamide1 Cytarabine1 Dolutegravir / Lamivudine1 Fludarabine1 Mecapegfilgrastim1 Ropivacaine1 Venetoclax1

Conditions in Affiliated Hospital of Nantong University trials

62 conditions

Ischemic Stroke3Refractive Surgery2Cardiovascular Diseases2Non-Proliferative Diabetic Retinopathy1Pressure Ulcers1Pressure Injuries1Myopia; Refractive Error1Knee Arthroscopic Surgery1PTSD - Post Traumatic Stress Disorder1taVNS1Dexmedetomidine1Sputum1Heart Failure1 Atrial Fibrillation (AF)1HFpEF - Heart Failure With Preserved Ejection Fraction1Rotator Cuff Tears1Micro Fracture1Gynecological Cancer1Analgesia1ICU Patients Requiring Invasive Mechanical Ventilation1Digital Health1Nasopharyngeal Carcinoma1 Stomach Neoplasms1Relapsed/refractory Lymphoma1

By trial register

Register	Trials	Recruiting
Clinical trials in China	36	26

A trial with sites in more than one country appears in each of those registers.

Other sponsors in Ischemic Stroke

Sponsor	Trials
Beijing Tiantan Hospital	10
General Hospital of Shenyang Military Region	10
Capital Medical University	7
Nanjing First Hospital, Nanjing Medical University	3
Zhujiang Hospital	3
Hui-Sheng Chen	2
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine	1
Shanghai IxCell Biotechnology	1

Sponsors with the most current trials registered for this condition.

Questions about Affiliated Hospital of Nantong University trials

How many clinical trials does Affiliated Hospital of Nantong University sponsor?

Affiliated Hospital of Nantong University is the lead sponsor of 36 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Affiliated Hospital of Nantong University trials recruiting?

Yes. 26 of its 36 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Affiliated Hospital of Nantong University testing?

Its current trials name 10 drugs and biologicals as interventions. The most frequent are Dexmedetomidine (3), 3TC (1), B/F/TAF (1), Cyclophosphamide (1) and Cytarabine (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.

Affiliated Hospital of Nantong University clinical trials